4588 — Oncolys Biopharma Share News
0.000.00%
Last trade - 00:00- ¥175bn
- ¥173bn
- ¥29m
Brief: Oncolys BioPharma applies phase II clinical trial of OBP-301 in U.S
Brief: Oncolys BioPharma to get patent for production method of OBP-601 (Censavudine) in Europe
Brief: Oncolys BioPharma to set up unit Oncolys USA
Brief: Oncolys Biopharma announces joint research agreement with Kyoto Prefectural University of Medicine
Table: Oncolys Biopharma -6-MTH parent results
Table: Oncolys Biopharma Inc. -2016 6-month parent forecast
Brief: Oncolys Biopharma to jointly research on OBP-301 with Japan-based university
Brief: Oncolys Biopharma says patent assessment in Japan for OBP-1101
Brief: Oncolys BioPharma signs joint research agreement
Brief: Oncolys Biopharma signs contract with WONIK CUBE
Brief: Oncolys Biopharma signs memorandum with Jiangsu Hengrui Medicine
Table: Oncolys Biopharma -Q1 parent results
Table: Oncolys Biopharma -2015 parent results
Table: Oncolys Biopharma -2015 parent forecast
Table: Oncolys Biopharma -9-MTH parent results